Do elevated fecal secretory IgA and stool inflammation point to noninfectious triggers when invasive infection markers are absent?

Determining the source of intestinal immune activation is crucial for guiding clinical management. When clinical markers of active, invasive infection are absent, elevations in mucosal immune and inflammatory markers point to noninfectious environmental and dietary triggers.

Clinical and inflammatory indicators

• Absence of invasive markers: The lack of pathogen-specific markers and indicators of severe tissue damage clinically opposes the presence of an active, invasive infection.
• Noninfectious triggers: Mildly elevated inflammatory profiles in a pathogen-free stool sample suggest that mucosal homeostasis is instead disrupted by non-invasive factors, such as celiac disease, dysbiosis, or food-related sensitivities.

Mechanistic pathways of mucosal response

• Secretory IgA (sIgA) mobilization: Fecal sIgA serves as a functional barrier defense that physically coats luminal microbes and dietary antigens to preserve mucosal integrity. Markedly elevated sIgA in the absence of infection represents active immune mobilization against these non-pathogenic luminal challenges, including dysbiosis, pathogenic overgrowth, or food antigen exposure.
• Neutrophilic infiltration: Fecal calprotectin acts as a quantitative marker reflecting mucosal neutrophil infiltration. When invasive pathogens are ruled out, calprotectin elevations indicate localized, noninfectious mucosal challenges rather than the destructive tissue processes associated with active infection.

Bottom line

• In the absence of invasive pathogen markers, elevated fecal sIgA and stool inflammation are highly consistent with noninfectious mucosal triggers—such as food antigens, celiac disease, or dysbiosis—rather than an active invasive infection.